A. “Dangerous drug” means any controlled substance classified in Schedule I, II, III, IV, or V of Chapter 69.50 RCW, excluding cannabis, as it now exists or shall hereafter be added to, deleted from, modified, or amended.

B. “Drug paraphernalia” has the same meaning as provided in RCW 69.50.102, excluding sterile hypodermic syringes, needles, and other objects used, intended for use, or designed for use in parenterally injecting controlled substances into the human body.

C. “Public place” means an area generally visible to public view and includes, without limitation, any place where the public has a right of access, which includes, without limitation, sidewalks, parking lots, parking garages, streets, driveways, alleys, highways, roads, tunnels, or bridges; public buildings and grounds, including schools, plazas, shelters, parks, playgrounds, and meeting halls; establishments to which the public is invited, including restaurants, theaters, stores, gas stations, meeting halls, lobbies, halls and dining rooms of hotels, bars, taverns, pubs, or establishments where beer or soft drinks may be sold, and their associated parking lots, parking structures, walkways, doorways, and entrances; railroad trains, light-rail facilities, transit stations, buses, and other public conveyances of all kinds and character, and their associated stations and platforms used in conjunction therewith which are open to unrestricted use and access by the public; automobiles visible to public view, whether moving or not; and all other places of like or similar nature.

D. “Use” means any effort taken in furtherance of an attempt to inject, ingest, inhale, or otherwise introduce a controlled substance into the human body. (Ord. 3438 § 2 (Exh. A), 2023)